Khalid Islam News Today

Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) Director Khalid Islam purchased 20,492 shares of Fennec Pharmaceuticals stock in a transaction that occurred on Thursday, November 16th. The shares were bought at an average cost of C$2.44 per share, for a total transaction of C$50,000.48. Fennec Pharmaceuticals Stock Up 2.5 % Shares of TSE:FRX opened […]

GANX | Complete Gain Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Good morning, ladies and gentlemen and welcome to the Fennec Pharmaceuticals Second Quarter 2023 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. Now, I would like to turn the conference over to Fennec’s […]

RESEARCH TRIANGLE PARK, N.C., June 12, 2023 -- Fennec Pharmaceuticals Inc. today announced that the nominees listed in the management proxy circular dated April 24, 2023 for the Annual General... | June 12, 2023

The president of the Palestinian Authority, PLO and Fatah, Mahmoud Abbas, refused to help lift the Israeli siege imposed on his predecessor Yasser Arafat due to the latters alleged support for the ...

Share: RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the "Company") (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14, 2021 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in Irvine, California and online on June 29, 2021. Detailed results of the vote for the election of directors are set out belo...

Gain Therapeutics Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain”) today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. and Hans Peter Hasler as independent members to its Board of Direct...

(2) BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. ("Gain") today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. and Hans Peter Hasler as independent members to its Board of Directors. The new board additions will provide strategic guidance as the company focuses on identifying and optimizing allosteric binding sites that have never before been targeted to unlock new treatment options for difficult-to-treat disorders characterized...